Unlocking the full
potential of life.
Unlocking the full
potential of life
Recordati established rare diseases operations in the Nordic and Baltic regions in 2007 as part of Recordati Rare Diseases.
In 2018 the Recordati Speciality and Primary Care business unit was incorporated together with the Rare Disease business unit in Recordati AB. Today Recordati AB operates across the Nordic and Baltic regions from our regional office in Stockholm, Sweden.
Learn More
https://166.117.139.23/wp-content/uploads/2024/05/Recordati-Corporate-Facts_2024.mp4
Recordati is a global international pharmaceutical company, listed on the Italian stock exchange, with over 4,450 employees. We develop and commercialise medicines to serve people living with common diseases, as well as those living with some of the rarest, in around 150 countries.
We are committed to being socially and environmentally responsible throughout all our activities